Pharma Service Provider Vetter Establishes New Site in Chicago

The pharmaceutical service provider received the corresponding building permit in April of this year, after which the first work began on the site. With an investment of around €250 million, the project underlines Vetter's sustained commitment to providing high-quality services for early clinical development.

Planned Start of Operations in 2029

The construction plans include an approximately 15,000m² clinical production facility for material preparation, solution manufacturing, and aseptic filling. Additional buildings will provide space for material storage, laboratories, and offices. The clinical site is expected to be completed by the end of 2029 and achieve "Ready for Mediafill" status. Vetter then plans to fully relocate the current clinical operations from Skokie to Des Plaines.

"This project marks another milestone in our international growth strategy," said Udo J. Vetter, Chairman of the Advisory Board and member of the owner family. "It underscores our commitment to quality and innovation, as well as our responsibility to our customers, partners, and patients around the world."

Vetter representatives, community representatives, and other guests gathered at the Des Plaines site for the ceremonial groundbreaking. During the event, the construction plans were presented and the importance of the project for Vetter was emphasized.

Flexible Expansion Options

The existing buildings on the Des Plaines site will be retained. With 80,000m², the site offers ideal conditions for strategic expansion, in line with international market movements, customer requirements, and the investment plans in Germany and Austria.

Founded in 1950 as a pharmacy in Ravensburg, the company is celebrating its 75th anniversary this year. Since then, the family business has stood for quality, responsibility, and great commitment to improving the quality of life of patients worldwide.